Abstract
Disruption in the normal timing of female puberty, as in pre-pubertal cancer treatments, can cause abnormal somatic development. CTX has been shown to hamper long bone and uterine development when administered to pre-pubertal mice. These effects are partially restored by low-dose estrogen treatment. We evaluated if high-dose estradiol could affect long-term uterine and somatic development.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
